Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar LonewolfNC (< 20) Submitted: 8/9/2008 12:37:16 PM : Outperform Start Price: $38.93 ONXX Score: +14.95

Onxx baby!

Featured Broker Partners


Advertisement